New Zealand markets open in 2 hours 23 minutes

PFE Jan 2026 32.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.9400+0.0900 (+4.86%)
As of 02:58PM EDT. Market open.
Full screen
Previous close1.8500
Open2.1000
Bid1.7200
Ask2.0300
Strike32.50
Expiry date2026-01-16
Day's range1.8100 - 2.1000
Contract rangeN/A
Volume134
Open interest6.09k
  • Zacks

    Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe

    Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.

  • Bloomberg

    Alnylam Soars After Drug Meets Goal in Heart Disease Trial

    (Bloomberg) -- Alnylam Pharmaceuticals Inc. shares soared after its drug succeeded in treating a progressive and deadly form of heart disease, potentially opening up a new avenue for the company’s top-selling product. Most Read from BloombergJain Global Raises $5.3 Billion, Secures Cash From Abu DhabiHow Long Can High Rates Last? Bond Markets Say Maybe ForeverBuzzFeed Struggles to Sell Owner of Hit YouTube Show ‘Hot Ones’Tech Hits Stocks as Nvidia Extends Selloff to 13%: Markets WrapNvidia Sales

  • Insider Monkey

    Did Seagen Acquisition Help Pfizer Inc. (PFE) Increase Revenue in Q1?

    We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other healthcare stocks. You can also check out the 20 Most Valuable Healthcare Companies in the World here. Healthcare stocks are […]